Evidence map›Paper›PMID 31002754›Full record

ArticleAndrology2019

Semen quality is affected by HLA class I alleles together with sexually transmitted diseases.

P I Marques, J C Gonçalves, C Monteiro, B Cavadas, L Nagirnaja, N Barros, A Barros, F Carvalho, A M Lopes, S Seixas

Open access · bronzeAbstract read
In one paragraph

Article in Andrology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 7 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. KIR and HLA-C genes in male infertility.Journal of assisted reproduction and genetics · 2020
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

P I MarquesInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.ORCID 0000-0001-6050-628X
J C GonçalvesInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.
C MonteiroInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.
B CavadasInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.
L NagirnajaDepartment of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
N BarrosCenter for Reproductive Genetics Alberto Barros, Porto, Portugal.
A BarrosInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.
F CarvalhoInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.
A M LopesInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.
S SeixasInstituto de Investigação e Inovação em Saúde, Universidade do Porto (i3S), Porto, Portugal.
Universidade do Porto · PTCentro de Genética Clínica · PTWashington University in St. Louis · US

Funding

GENOMICS OF SPERMATOGENIC IMPAIRMENTR01HD078641 · NICHD · WASHINGTON UNIVERSITY · PI Kenneth Ivan Aston, DONALD F. CONRAD · 2014 to 2026
$6.3M
Mechanisms of concomitant tumor immunity and autoimmunityR01CA120777 · NCI · DARTMOUTH COLLEGE · PI TURK, MARY JO · 2006 to 2016
$2.5M
Eunice Kennedy Shriver National Institute of Child Health and Human Development R01HD07864European Regional Development Fund NORTE-01-0145-FEDER-000029European Regional Development Fund POCI-01-0145-FEDER-007274Fundação para a Ciência e a Tecnologia IF/01262/2014Fundação para a Ciência e a Tecnologia PTDC/BEX- GMG/0242/2012Fundação para a Ciência e a Tecnologia SFRH/BPD/120777/2016NICHD NIH HHS R01 HD078641
6 · The paper itself

Abstract

backgroundThe human leukocyte antigen (HLA) locus includes several genes with key roles in antigen presentation and immune response, some of them inclusively found to be associated with non-obstructive azoospermia. Still, HLA connections to other infertility phenotypes such as semen hyperviscosity (SHV), asthenozoospermia (AST), and oligozoospermia (OLI) have been often neglected.

objectivesIn this work, we aimed to evaluate the association of HLA class I and II genes with SHV, AST, and OLI phenotypes while exploring a possible role in an adaptive immune response to sexually transmitted diseases (STD). MATERIALS AND

methodsWhole-exome sequencing was performed in a Portuguese cohort of 71 infertility cases and 68 controls, followed by HLA typing using a specific software-HLA*PRG:LA tool. Molecular screenings of seven STD were carried out in a subset of 72 samples (30 cases and 42 controls).

resultsStatistical tests uncovered three protective alleles: HLA-A*11:01, associated with all forms of male infertility (p = 0.0006); HLA-DQB1*03:02 with SHV and OLI (P

conclusionsThe application of HLA*PRG:LA tool to the study of male infertility provided novel insights for an HLA correlation with semen quality, namely among SHV and OLI phenotypes. The discovery of an HLA-A*29:02/HPV crosstalk, together with former reports of HLA alleles conferring resistance-susceptibility to diverse human pathogens, raises the hypothesis of a mechanistic link between male infertility, HLA polymorphism, and host response to STD.

Indexed as

AdultAsthenozoospermiaAzoospermiaGene DosageGene Expression ProfilingGenetic Predisposition to DiseaseHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-A AntigensHLA-B AntigensHLA-C AntigensHLA-DQ beta-ChainsHumansMaleOligospermiaSemen AnalysisHistocompatibility Antigens Class IHistocompatibility Antigens Class IIHLA-A AntigensHLA-B AntigensHLA-C AntigensHLA-DQB1 antigenHLA-DQ beta-Chainsassociation studyHLA-AHPVmale infertilityoligozoospermiasemen hyperviscosity

Identifiers

PMID31002754
PMCPMC6768700
OpenAlexW2935837641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.